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Abstract Rosmarinic acid is the dominant hydroxycinnamic
acid ester accumulated in Boraginaceae and Lamiaceae plants. A
cytochrome P450 cDNA was isolated by differential display
from cultured cells of Lithospermum erythrorhizon, and the gene
product was designated CYP98A6 based on the deduced amino
acid sequence. After expression in yeast, the P450 was shown to
catalyze the 3-hydroxylation of 4-coumaroyl-4P-hydroxyphenyl-
lactic acid, one of the final two steps leading to rosmarinic acid.
The expression level of CYP98A6 is dramatically increased by
addition of yeast extract or methyl jasmonate to L. erythrorhizon
cells, and its expression pattern reflected the elicitor-induced
change in rosmarinic acid production, indicating that CYP98A6
plays an important role in regulation of rosmarinic acid bio-
synthesis. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
A remarkably diverse array of cytochrome P450s is utilized
in both biosynthetic and detoxi¢cation pathways in higher
plants. The Arabidopsis genome project has revealed 273 cy-
tochrome P450 genes clustered in 45 CYP families in this
species (http://drnelson.utmem.edu/CytochromeP450.html),
most of which have not yet been functionally characterized.
P450 gene products often appear to form key regulatory steps
in plant secondary metabolism, as exempli¢ed during sesqui-
terpene biosynthesis in cotton [1].
Rosmarinic acid (K-O-ca¡eoyl-3,4-dihydroxyphenyllactic
acid, RA) is a prominent hydroxycinnamic acid ester that
accumulates in Boraginaceae and Lamiaceae plants. RA ex-
hibits various pharmacological activities including prevention
of oxidation of low density lipoprotein [2], inhibition of mur-
ine cell proliferative activity [3] and of cyclooxygenase [4], and
anti-allergic action [5]. The biosynthesis and production of
RA have been extensively studied using cell and organ culture
systems because (1) RA is a potentially useful compound as a
medicine and a food additive, and (2) RA biosynthesis repre-
sents an interesting model system in which two parallel bio-
synthetic pathways must be regulated in a coordinated man-
ner. Earlier radiotracer studies established that the ca¡eic acid
moiety and the 3,4-dihydroxyphenyllactic acid moiety are de-
rived from phenylalanine and tyrosine, respectively [6]. RA
synthase [7] catalyzed the condensation of 4-hydroxyphenyl-
lactic acid, derived from tyrosine, with 4-coumaroyl-CoA
formed through the phenylpropanoid pathway, to yield K-O-
4-coumaroyl-4P-hydroxyphenyllactic acid (CHPL). CHPL is
then converted to RA through two consecutive hydroxylation
reactions as shown in Fig. 1. Of the three hydroxylation steps
required to form RA, the ¢rst (hydroxylation of trans-cinnam-
ic acid to form 4-coumaric acid) is catalyzed by cinnamic acid
4-hydroxylase (C4H). Two C4H cDNAs have been cloned
from Lithospermum erythrorhizon (Boraginaceae) and charac-
terized as CYP73A30 and CYP73A31 [8]. Much less is known
about the ¢nal two hydroxylation steps. The relevant enzyme
activity has been detected in microsomal preparation from
Coleus blumei (Lamiaceae) [9] but has yet to be fully charac-
terized.
RA formation in L. erythrorhizon cell suspension cultures is
rapidly and transiently stimulated by addition of yeast extract
(YE) or methyl jasmonate (MJ) [10^11], providing a conve-
nient system for analysis of the molecular events that regulate
RA biosynthesis. Elicitation by YE or MJ induced increased
activities of both phenylalanine ammonia-lyase (PAL) and 4-
hydroxyphenylpyruvate reductase (HPR), entrypoint enzymes
for the phenylpropanoid pathway and tyrosine-derived path-
way, respectively. Similar e¡ects of YE or MJ treatment on
RA biosynthesis have also been reported in Orthosiphon aris-
tatus [12] and C. blumei [13] cell suspension cultures, and in
hairy root cultures of Salvia miltiorrhiza [14].
In order to gain insight into the molecular mechanisms
underlying RA biosynthesis, we have undertaken di¡erential
display analysis of genes induced during elicitation of RA
biosynthesis after YE addition to L. erythrorhizon cultured
cells. In the present paper we describe a cDNA encoding a
cytochrome P450 protein (CYP98A6), whose encoded protein
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was found to catalyze the 3-hydroxylation of a phenolic ester,
CHPL, which is a central intermediate in the RA biosynthetic
pathway. We also con¢rmed that expression of this gene is
rapidly induced in L. erythrorhizon cells by YE or MJ treat-
ment, concomitantly with the induction of RA biosynthesis.
2. Materials and methods
2.1. Plant cell culture and elicitor treatment
Suspension cultures of L. erythrorhizon Sieb. et Zucc. were estab-
lished from seedling-derived callus tissues and maintained in LS liquid
medium [15] supplemented with 1 WM 2,4-dichlorophenoxyacetic acid
and 1 WM kinetin. Cell suspension (5 ml) was transferred into 25 ml
fresh medium in a 100-ml Erlenmeyer £ask at 14-day intervals and
cultured on a rotary shaker at 25‡C in the dark. Yeast extract (Difco)
was dissolved in water, autoclaved at 120‡C for 20 min, and asepti-
cally added to the cell suspension at a ¢nal concentration of 5 g/l. MJ
(Tokyo Kasei) was dissolved in dimethylsulfoxide and added to the
cultures through a membrane ¢lter to give a ¢nal concentration of 100
WM. These elicitors were added to the cells 7 days after cell transfer
and the cells were collected by vacuum ¢ltration at de¢ned times,
immediately frozen in liquid nitrogen, and stored at 380‡C.
2.2. Isolation and analysis of RNA
Total RNA was extracted from the frozen cells using TRIzol (In-
vitrogen) according to a protocol supplied by the manufacturer.
Poly(A) RNA was prepared from the YE-treated cells 8 h after
YE addition, using a Quick Prep mRNA Puri¢cation Kit (Amersham
Pharmacia Biotech). The cDNA library was constructed using a
VZAP-cDNA Synthesis/Gigapack Gold Packaging kits (Stratagene).
For Northern hybridization, total RNA (20 Wg) was fractionated in
a formaldehyde^1.25% agarose gel and transferred onto Hybond N
membrane (Amersham Pharmacia Biotech). Hybridization with
digoxigenin-labeled probes and chemiluminescent detection were car-
ried out according to a protocol supplied by Roche Biochemicals.
2.3. Di¡erential display
Di¡erential display was performed essentially as described by Yosh-
ida et al. [16] with some modi¢cations. The DNase I-treated total
RNA (200 ng) was reverse-transcribed in 10 Wl reverse transcription
bu¡er containing 0.9 mM MnCl2, 0.25 mM dNTP, 0.8 WM 12-mer
arbitrary primer (Wako Pure Chemical Industries) and 1 U Tth DNA
polymerase (Roche Biochemicals) at 40‡C for 30 min. PCR was then
performed in 50 Wl reaction mixture containing 10 Wl of the reverse
transcription mixture, 40 Wl PCR bu¡er (Roche Biochemicals) and
0.75 mM EGTA. In the present protocol, a single arbitrary primer
was used for both reverse transcription and PCR. PCR was carried
out in a Perkin Elmer Model 2400 Thermal Cycler using the following
parameters: denaturing at 94‡C for 3 min, followed by 40 cycles at
94‡C for 1 min, 40‡C for 1 min and 72‡C for 2 min, and then a ¢nal
extension at 72‡C for 5 min. The PCR products were separated by
1.5% agarose gel electrophoresis and visualized by ethidium bromide
staining. Di¡erential displayed cDNA bands were recovered from the
gel, re-ampli¢ed with the A07A primer (5P-GATGGATTTGGG-3P)
and cloned into pGEM-T vectors (Promega). The pGEM-T clone
inserts were sequenced for both strands using the Thermo Sequenase
Cycle Sequencing Kit (Amersham Pharmacia Biotech). The inserts
were digoxigenin-labeled with the PCR DIG Probe Synthesis Kit
(Roche Biochemicals) and used as a probe for Northern hybridization
and library screening.
2.4. Expression of CYP98A6 in Saccharomyces cerevisiae
For construction of the pYES2-CYP98A6 expression vector, the
open reading frame of CYP98A6 was ampli¢ed by PCR using Pfu
DNA polymerase (Promega) with primers 5P-CGGGGTAC-
CATGGCCCTGCCAGCCATACCCCTA-3P and 5P-GGTCTAGAT-
TACATGTCCGACTCGACTCGTT-3P. These primers correspond to
the 5P and 3P ends of the open reading frame and introduce a KpnI site
upstream of the start codon and a XbaI site downstream of the stop
codon. PCR was carried out as recommended by Promega. Upon
completion of the PCR cycle, the PCR mixture was incubated for
another 2 min at 72‡C with 3 U of Taq DNA polymerase (Roche
Biochemicals). The resulting 1.5-kb PCR product was ligated into a
pGEM-T vector (Promega), sequenced to ensure that no mutation
was incorporated, and subcloned into KpnI^XbaI-digested pYES2
(Riken DNA Bank, Japan). The resulting yeast expression vector
was transformed into S. cerevisiae strain INVSc1 (Invitrogen) by elec-
troporation. The transformed yeast cells were grown as described
previously [8], and microsomes were prepared according to the meth-
od of Guengerich et al. [17] 16^22 h after induction with galactose.
Protein content in the microsomal fraction was estimated using the
method of Bradford [18].
2.5. Enzyme assay
The standard assay mixture for CHPL 3-hydroxylase activity con-
tained in a total volume of 400 Wl of 100 mM sodium phosphate
bu¡er, pH 7.5, 0.56 mg microsomal protein from yeast, and 12
nmol ( þ )-CHPL and 24 nmol NADPH. ( þ )-CHPL was synthesized
as described elsewhere [19]. The reaction was incubated at 25‡C for 30
min and terminated by addition of 40 Wl acetic acid. Reaction prod-
ucts were extracted three times with 800 Wl ethyl acetate. The pooled
ethyl acetate extract was evaporated under vacuum, and the residue
was dissolved in 30 Wl MeOH^0.1% acetic acid (1:1) and subjected to
HPLC analysis. HPLC conditions: column, Cosmosil 5C18-MS
(4.6U150 mm I.D.; Nakarai Tesque); elution, MeOH^0.1% acetic
acid (1:1) at a £ow rate of 1 ml/min. The absorbance of the eluate
was monitored with a diode array detector. The retention times of the
product and the substrate were 5.0 min (for CHPL) and 4.2 min (for
the enzyme product), respectively. For identi¢cation of the product,
Fig. 1. The proposed biosynthetic pathway leading to rosmarinic
acid. PAL, phenylalanine ammonia-lyase; C4H, cinnamic acid 4-hy-
droxylase; 4CL, 4-coumaric acid:CoA ligase; TAT, tyrosine amino-
transferase; HPR, 4-hydroxyphenylpyruvate reductase; RS, rosmar-
inic acid synthase.
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HPLC eluate corresponding to the product peak was pooled, evapo-
rated and analyzed by the FAB-MS and 1H-NMR spectra using a
JEOL JMS SX-102 spectrometer and a JEOL JNM Lambda 400 (400
MHz) spectrometer, respectively. The CD spectra of the product and
authentic RA (purchased from Funakoshi, Japan) were measured us-
ing a JASCO J-725 Spectropolarimeter in ethanol at 25‡C.
2-O-Ca¡eoyl-3-(4-hydroxyphenyl)lactic acid : FAB-MS; m/z : 367
[M+Na]. 1H-NMR (abbreviations: s, singlet; d, doublet; dd, doublet
of doublets; m, multiplet); (CD3OD) N : 3.12^3.13 (1H, m, CHaHb-
Ph), 3.16 (1H, d-like, J = 7.3 Hz, CHaHb-Ph), 5.01 (1H, m, OCH6 ),
6.25 (1H, d, J = 15.9 Hz, PhCHNCH), 6.68 (2H, d, J = 8.3 Hz, Ar^H),
6.75 (1H, d, J = 8.3 Hz, Ar^H), 6.91 (1H, dd, J = 2.0, 8.3 Hz, Ar^H),
7.01 (1H, d, J = 2.0 Hz, Ar^H), 7.12 (2H, d, J = 8.3 Hz, Ar^H), 7.49
(1H, d, J = 15.9 Hz, CO^CHNCH).
2.6. Quantitative determination of RA
The frozen cells (about 0.2 g) were extracted with 2 ml methanol at
65‡C for 60 min with vigorous shaking. The slurry was centrifuged at
12 000Ug for 5 min and the supernatant was subjected to HPLC. The
conditions for HPLC analysis have been described previously [10].
3. Results
3.1. CYP98A6 cDNA was cloned as a YE-inducible gene by
di¡erential display
By a simpli¢ed di¡erential display approach three YE-in-
ducible cDNA clones (F86A, F86B and A07A) were obtained
and sequenced. Characterization of the F86A and F86B
cDNA fragments will be reported elsewhere. A BLAST search
using about 700 bp of the A07A sequence showed that the
nucleotide sequence is similar to those of various plant cyto-
chrome P450s. The A07A fragment was digoxigenin-labeled
and used as a probe to screen about 250 000 plaques from a
cDNA library constructed from the YE-treated L. erythrorhi-
zon cells. After three rounds of plaque hybridization, a cDNA
clone covering the entire protein coding region was isolated
and sequenced. The cDNA clone was 1702 bp long with an
open reading frame corresponding to 506 amino acids, a 41-
bp 5P non-coding sequence and a 140-bp 3P non-coding re-
gion. The deduced amino acid sequence displayed the pres-
ence of evolutionarily conserved regions typical of all cyto-
chrome P450s, including a proline-rich region immediately
after the N-terminal hydrophobic sequence, a threonine-con-
taining binding pocket for the oxygen molecule and a heme-
binding region [20]. A search of DDBJ/EMBL/GenBank data-
bases revealed that the encoded protein shared 60^65% amino
acid sequence identity with other cytochrome P450 proteins
belonging to the CYP98A subfamily, and the protein was
designated CYP98A6 by the Committee on Cytochrome
P450 Nomenclature (D.R. Nelson, personal communication).
3.2. CYP98A6 speci¢cally hydroxylates the coumaroyl moiety
of CHPL
To examine the catalytic function of the gene product
CYP98A6 was heterologously expressed in yeast cells. Three
cytochrome P450s are presumed to be involved in RA biosyn-
thesis ; one is C4H and the others would be required for two
subsequent hydroxylation steps which convert CHPL to RA.
Since C4H cDNAs have already been isolated from L. eryth-
Fig. 2. HPLC analysis of the product formed from CHPL by incu-
bation with recombinant CYP98A6. CHPL was incubated for 0, 5
and 20 min at 25‡C with 0.56 mg microsomal protein from the in-
duced yeast harboring pYES-CYP98A6. The insets show UV ab-
sorption spectra corresponding to peaks 1 and 2.
Fig. 3. 1H-NMR spectra of CHPL (above) and the reaction product
with the recombinant CYP98A6 (below). The numerals in the spec-
tra indicate the assigned protons.
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rorhizon and identi¢ed as CYP73A30 and CYP73A31 [8], we
used CHPL as a candidate substrate for assay of CYP98A6
enzyme activity. As shown in Fig. 2, recombinant CYP98A6
converted CHPL into a more hydrophilic compound. The
conversion rate was linearly correlated with both time (up
to 60 min) and microsome concentration (up to 1.3 mg micro-
somal protein). The reaction was also completely dependent
on NADPH.
To determine the chemical structure of the product, the
HPLC eluate containing the product was pooled, concen-
trated and subjected to NMR, MS and CD measurements.
The FAB-MS spectrum of the product showed a pseudo mo-
lecular ion peak at m/z 367 [M+Na], 16 mass units larger than
the substrate. The 1H-NMR spectrum of the product indi-
cated the presence of one tri-substituted phenyl group (N
6.75, 6.91 and 7.01 ppm) and one para-substituted phenyl
group (N 6.68 and 7.12 ppm), a trans-ole¢n (N 6.25 and 7.49
ppm) and a CH^CH2 system (N 5.01, 3.12^3.13 and 3.16 ppm)
as shown in Fig. 3. Irradiation of the ole¢n signal at 6.25 ppm
induced 5.1 and 5.9% nuclear Overhauser e¡ects on the aro-
matic proton signals at 6.91 and 7.01 ppm, respectively. These
results indicate that the product possesses a ca¡eoyl moiety
rather than a 3,4-dihydroxyphenyllactic acid moiety. The sub-
strate, CHPL, had therefore been hydroxylated by CYP98A6
at the 3-position of the coumaroyl moiety to produce ca¡eoyl-
4P-hydroxyphenyllactic acid. Comparison of the CD spectra
(data not shown) between the product and naturally occurring
RA indicated that the stereochemistry of the product is same
as that of RA, namely the R-form, although the substrate
CHPL is a racemic mixture. Formation of RA could not be
detected even when the reaction was continued for prolonged
periods. Cinnamic acid, 4-coumaric acid and 4-coumaroyl-
CoA were tested as substrates for hydroxylation, but none
of these compounds was converted to the expected products,
4-coumaric acid, ca¡eic acid and ca¡eoyl CoA, respectively.
3.3. CYP98A6 expression is induced by various elicitors that
also induce RA biosynthesis
In order to characterize the relationship between CYP98A6
expression and RA biosynthesis, we analyzed the changes in
CYP98A6 mRNA level and in RA accumulation following
di¡erent elicitor treatments (Fig. 4). RA accumulation in L.
erythrorhizon cells started to increase gradually within 4^8 h
after YE addition, followed by a rapid increase until 24 h.
Expression of CYP98A6 rose within 4 h after YE treatment,
reached a peak at 24 h and thereafter decreased, consistent
with the YE-induced changes in RA accumulation. MJ treat-
ment, on the other hand, induced a larger increase in RA
accumulation than did YE treatment, but the response of
the cells to MJ was slower. RA production started to increase
8 h after MJ addition, and rose rapidly until 48 h after MJ
treatment. A similar delay was observed in CYP98A6 expres-
sion. Expression of PAL was also increased by YE or MJ
treatment, but the extent of the increase was much smaller
compared with CYP98A6.
4. Discussion
Characterization of plant cytochrome P450s by convention-
al biochemical approaches has been hampered by the low
abundance and instability of these membrane-bound proteins.
The relatively high degree of sequence conservation within the
CYP superfamily has made it possible to use sequence-based
PCR cloning to isolate plant cytochrome P450 genes [21], but
this approach does not reveal the function of the encoded
gene products unless the expressed protein can be assayed
against appropriate substrates. T-DNA tagging provides an
alternative method for unambiguously associating a given
P450 gene with an in vivo metabolic function [22], but this
is a time-consuming approach and applicable only within a
limited number of species, such as Arabidopsis.
In this study we cloned a cytochrome P450 cDNA,
CYP98A6, from elicited L. erythrorhizon suspension cultures
using the di¡erential display technique and established that
CYP98A6 catalyzed the 3-hydroxylation of the hydroxycinna-
moyl moiety of R-CHPL to form ca¡eoyl-4P-hydroxyphenyl-
lactic acid, an immediate precursor of RA. This enzymatic
activity had been detected in microsomes prepared from C.
blumei suspension cells, based on the NADPH dependence,
Fig. 4. Changes in RA accumulation and mRNA levels of
CYP98A6 and of PAL in L. erythrorhizon suspension cultures after
the addition of YE or MJ. The elicitors were added to the cultures
7 days after cell inoculation. The L. erythrorhizon PAL cDNA,
which was generously provided by Dr. K. Yazaki of Kyoto Univer-
sity, was digoxigenin-labeled using the PCR DIG Probe Synthesis
Kit and used as a probe. Dimethylsulfoxide was added to the con-
trol cultures.
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inhibitor sensitivity and partially photoreversible carbon mon-
oxide inhibition of the activity [9]. We have also observed that
L. erythrorhizon microsome preparations supplemented with
NADPH can e⁄ciently convert CHPL to RA (data not
shown). These observations point to the presence of two hy-
droxylating functions, but no further characterization of the
hydroxylases involved has been reported.
Our results indicate that CYP98A6 represents the ¢rst of
the two hydroxylases required to complete the RA biosyn-
thetic pathway. Recombinant CYP98A6 converts CHPL ex-
clusively to ca¡eoyl-4P-hydroxyphenyllactic acid rather than
4-coumaroyl-3P,4P-dihydroxyphenyllactic acid, and is unable
to convert ca¡eoyl-4P-hydroxyphenyllactic acid to RA. This
indicates that a second hydroxylase, responsible for 3P-hy-
droxylation of the 4P-hydroxyphenyllactic acid moiety, still
remains to be discovered.
Despite the abundance of 3,4-dihydroxyphenylpropanoid
metabolites found in plants, attempts to identify the enzyme(s)
responsible for introduction of the 3-hydroxyl group to a 4-
hydroxylated precursor have only recently met with notable
success. 5-Hydroxylation of ferulic acid and its derivatives,
such as coniferylaldehyde and coniferyl alcohol, has been
shown to be catalyzed by ferulate-5-hydroxylase, a cyto-
chrome P450 protein designated CYP84A1 [23]. In contrast,
3-hydroxylation of the 4-hydroxylated £avonoid B ring is cat-
alyzed by a £avonoid 3P-hydroxylase belonging to a di¡erent
P450 subfamily, CYP75B. Recently, Schoch et al. reported
that CYP98A3 from Arabidopsis thaliana catalyzes 3-hydrox-
ylation of shikimate and quinate esters of 4-coumaric acid to
form corresponding ca¡eoyl esters [24]. This reaction is sim-
ilar to the conversion of CHPL to ca¡eoyl 4-hydroxyphenyl-
lactic acid, insofar as the primary substrate is a p-coumaroyl
ester of a bulky hydrophilic acid.
A phylogenetic tree of various plant cytochrome P450s
(Fig. 5) con¢rmed that among CYP98A members,
CYP98A6 is most closely related to CYP98A3. CYP98A8
and CYP98A9, two other CYP98A members from A. thali-
ana, constitute a di¡erent cluster, and neither exhibits 3-hy-
droxylation activity against the phenolic esters [24]. Interest-
ingly, CYP98A6 shares more sequence homology with C4H
(CYP73A) than it does with F3PH (CYP75B), in spite of the
fact that both CYP98A6 and F3PH catalyze 3-hydroxylation
of a 4-hydroxylated aromatic ring. This suggests that the ca-
pacity to form ortho-dihydroxyphenylpropanoid metabolites
may have evolved from an ancestral hydroxylase responsible
for the original conversion of the unsubstituted cinnamic acid
ring to its 4-hydroxy derivative.
The expression pattern of CYP98A6 in cultured cells of L.
erythrorhizon treated with elicitors is closely linked to elicitor-
induced RA biosynthesis. RA production is stimulated more
than 15-fold by addition of MJ, while the activities of PAL in
the general phenylpropanoid pathway and HPR in tyrosine-
derived pathway are induced only up to ¢ve-fold [9]. By con-
trast, CYP98A6 expression was massively stimulated by MJ
treatment. The striking increase in CYP98A6 transcript levels
after YE or MJ treatments, together with its demonstrated
catalytic function, clearly places CYP98A6 in the RA biosyn-
thetic pathway, and may indicate that CYP98A6 plays a cru-
cial role in regulation of the rate of RA formation.
While a key element in RA biogenesis has been discovered,
unanswered questions remain. For example, CYP98A6 is
clearly capable of introducing a 3-hydroxyl group to CHPL
to form the ca¡eoyl derivative which can then be converted to
RA by a second 3P-hydroxylase acting on the 4P-hydroxyphen-
yllactic acid moiety. However, at this point we cannot exclude
the possibility that CYP98A6 may normally catalyze 3-hy-
droxylation of 4-coumaroyl-3P,4P-dihydroxyphenyllactic acid
that has been ¢rst formed from CHPL by the other 3P-
hydroxylase (Fig. 1). Assay of recombinant CYP98A6 against
4-coumaroyl-3P,4P-dihydroxyphenyllactic acid will require
preparation of this intermediate in the biosynthetic pathway,
work which is now under way. Identi¢cation and character-
ization of the enzyme responsible for 3P-hydroxylation of the
hydroxyphenyllactic moiety will also help to resolve this ques-
tion. The relatively unreactive nature of the aromatic ring of
4P-hydroxyphenyllactic acid, compared to the more highly
conjugated and reactive hydroxycinnamic acids, suggests
that this hydroxylase may have signi¢cantly di¡erent proper-
ties from the enzymes characterized to date.
While Lithospermum CYP98A6 and Arabidopsis CYP98A3
are clearly evolutionarily related gene products, the speci¢city
of CYP98A6 for RA biosynthesis, and of CYP98A3 for qui-
nate/shikimate ester biosynthesis, remains uncertain. It is pos-
sible that CYP98A6 is not a speci¢c enzyme for RA biosyn-
thesis but represents a broader-speci¢city enzyme derived
from CYP98A3, and that it still supports general phenylpro-
panoid biosynthesis in Lithospermum. To examine this ques-
tion more closely, the ability of CYP98A6 to use shikimate
and quinate esters of 4-coumaric acid as substrates, and of
CYP98A3 to use CHPL, is also under investigation.
In summary, by using a di¡erential display we have cloned
from L. erythrorhizon suspension cultures a cDNA encoding a
novel cytochrome P450-dependent monooxygenase (CYP-
98A6), and have demonstrated that the enzyme catalyzes
Fig. 5. Phylogenetic tree showing the relationship between the de-
duced amino acid sequences of CYP98A6 and some other plant
P450s. The amino acid sequences were aligned using ClustalW and
the tree was constructed by the neighbor-joining (NJ) method in
PHYLIP software package (J. Felsenstein, Phylogeny Inference
Package, version 3.573, University of Washington, Seattle, WA,
USA). Applying other tree-constructing algorithms such as UPGMA
and parsimony methods gave essentially the same topology. The
tree was rooted using the CYP51A1 sequence as the outgroup. The
branch length does not re£ect genetic distance between two clusters.
F3PH, £avonoid-3P-hydroxylase; F3P5PH, £avonoid-3P,5P-hydroxy-
lase; F5H, ferulate-5-hydroxylase; LMO, lauric acid monooxyge-
nase; HCE3H, hydroxycinnamoyl ester-3-hydroxylase.
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3-hydroxylation of a hydroxycinnamic acid ester involved in
one of the ¢nal steps in RA biosynthesis. CYP98A6 may
prove to be useful for manipulation of RA productivity via
genetic engineering.
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